Zhang; Songwen
Patent Applications and Registrations
Patent applications and USPTO patent grants for Zhang; Songwen.The latest application filed is for "methods and compositions for selective inhibition of ligand binding to the lectin-like receptor for oxidized low density lipoprotein (lox-1)".
- Zhang; Songwen - Lansdale PA
- Zhang; Songwen - Cambridge MA
| Patent | Date |
|---|---|
| Methods and Compositions for Selective Inhibition of Ligand Binding to the Lectin-Like Receptor for Oxidized Low Density Lipoprotein (LOX-1) App 20090311271 - Harnish; Douglas Carl ; et al. | 2009-12-17 |
| FXR Agonists for the Treatment of Nonalcoholic Fatty Liver and Cholesterol Gallstone Diseases App 20090163474 - Zhang; Songwen ; et al. | 2009-06-25 |
| Inducible heart attack animal model Grant 7,514,592 - Krieger , et al. April 7, 2 | 2009-04-07 |
| FXR Agonists for Reducing LOX-1 Expression App 20080300235 - Harnish; Douglas ; et al. | 2008-12-04 |
| Inducible heart attack animal model App 20050223420 - Krieger, Monty ; et al. | 2005-10-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 